17 alpha-hydroxyprogesterone caproate and Polycystic Ovary Syndrome

17 alpha-hydroxyprogesterone caproate has been researched along with Polycystic Ovary Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abendstein, BJ; Kreuzer, E; Rjosk, HK; Schwärzler, P	1

Other Studies

1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Polycystic Ovary Syndrome

Article	Year
Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients. Human fertility (Cambridge, England), 2001, Volume: 4, Issue:4 Topics: 17 alpha-Hydroxyprogesterone Caproate; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Hydroxyprogesterones; Infertility, Female; Injections, Intramuscular; Ovarian Hyperstimulation Syndrome; Ovary; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Risk Factors	2001

Article

Year

Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients.

Human fertility (Cambridge, England), 2001, Volume: 4, Issue:4

Topics: 17 alpha-Hydroxyprogesterone Caproate; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Hydroxyprogesterones; Infertility, Female; Injections, Intramuscular; Ovarian Hyperstimulation Syndrome; Ovary; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Risk Factors

2001